MAYRA POZO: Open Payments
NPI 1578193447 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,143 in 88 payments from 9 companies in 2025. Trend: 2023 $1,203 · 2024 $3,226 · 2025 $7,143
Consulting: $4,332Food & beverage: $2,760Speaker / faculty: $37Travel & lodging: $14
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 17 | $4,557 |
| Abbott Laboratories | 34 | $1,112 |
| MDD US Operations, LLC | 23 | $717 |
| Medtronic, Inc. | 5 | $405 |
| Boston Scientific Corporation | 1 | $104 |
| InSightec,Inc | 1 | $93 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| UCB, Inc. | 1 | $37 |
Products named: CREXONT, INFINITY, PERCEPT PC BRAINSENSE, General - DBS, Exablate, Gocovri, AUSTEDO XR, INGREZZA.
Industry payments across NY — which companies pay providers there.
